Skip to main content
Premium Trial:

Request an Annual Quote

Keck Futures Initiative Awards $1M in Grants for Genomics and Infectious Disease Research

NEW YORK, April 11 (GenomeWeb News) - The National Academies Keck Futures Initiative yesterday announced the recipients of its 2005 Futures grants.

 

The initiative awarded 14 total grants, each in the amount of $50,000 or $75,000, to support interdisciplinary research on genomics and infectious disease.

 

The recipient institutions, amounts, and research topics are:

 

-- North Carolina State University, Yale University School of Medicine, and University of Maryland, College Park; $75,000; "The Co-evolution of Human and Plasmodium Genomic Interactions."

-- University of California, Los Angeles; $75,000; "Exploring the Emerging Role of Public Health in Integrating Genomics into the Control and Prevention of Infectious Diseases."

-- University of California, Berkeley, and Mount Sinai School of Medicine; $75,000; "Metagenomic Studies of Human Microbiota in Crohn's Disease."

 

-- University of Pennsylvania School of Medicine and University of Colorado, Boulder; $75,000; "Dynamics of the Human Intestinal Flora in Health and Disease."

 

-- Duke University; $75,000; "Engineering 'Microbial Swarmbots' for Medical Applications."

 

-- University of Texas Health Science Center and Brandeis University; $50,000; "Identification of Isocitrate Lyase Inhibitors as Broad-Spectrum Antimicrobial Drugs."

-- University of Washington and Harvard Medical School; $75,000; "Role of Nitric Oxide on White Blood Cell Function in Inflammation and Infection."

 

-- University of Washington; $75,000; "Direct Electronic Detection of Molecular Recognition and Binding Events with Engineered Nano-Scale Structures."

-- University of Maryland School of Medicine; $75,000; "Genetic Diversity and Efficacy of Malaria Drugs and Vaccines."

 

-- Stanford University and University of California, Los Angeles; $75,000; "Bringing Genomics to the Rainforest: The Study of Monkeypox in the Democratic Republic of Congo."

 

-- Duke University and University of California, Riverside; $75,000; "Creating an Inexpensive Diagnostic for Malaria Using Combined Nanotechnology and Genomic Approaches."

 

-- Texas A&M University, and CombiMatrix; $75,000; "Enhancement of DNA Microarray Hybridization Using Thermal Gradient Induced Convective Flow."

 

-- Stanford University and Stanford Genome Technology Center; $50,000; "Low Cost and Rapid Microbe Diagnostics to Combat Drug Resistance Phenomenon in Infectious Diseases."

 

-- University of Texas Medical Branch and University of Denver; $75,000; "Micro Incubator for Bacterial Infectious Agents."

 

The National Academies comprises the National Academy of Sciences, National Academy of Engineering, and Institute of Medicine. The Keck Futures Initiative is a 15-year effort to foster interdisciplinary scientific research.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.